Log in to search using one of your social media accounts:

 

FDA warns Magellan Diagnostics of significant violations of the law as part of investigation into lead testing issues
Today the U.S. Food and Drug Administration issued a warning letter to Magellan Diagnostics Inc. for several violations of federal law, including marketing significantly modified versions of two of its blood lead testing systems without the FDA ’s required clearance or approval and failing to submit medical device reports to the FDA after becoming aware of customer complaints involving discrepancies in blood lead test results. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 23, 2017 Category: American Health Source Type: news

Nigeria:Tobacco Company Denies Targeting Children
[Premium Times] The British American Tobacco has denied that its marketing strategies target the younger generation by deliberately situating tobacco products near primary and secondary schools in Nigeria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 23, 2017 Category: African Health Source Type: news

Machine learning to detect prescription opioid abuse promotion and access via Twitter - Mackey TK, Kalyanam J, Katsuki T, Lanckriet G.
OBJECTIVES: To deploy a methodology accurately identifying tweets marketing the illegal online sale of controlled substances. METHODS: We first collected tweets from the Twitter public application program interface stream filtered for prescription ... (Source: SafetyLit)
Source: SafetyLit - October 23, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Appropriate targets for search advertising as part of online gatekeeping for suicide prevention - Sueki H, Ito J.
We examined the association between the outcomes of online gatekeeping using the I... (Source: SafetyLit)
Source: SafetyLit - October 23, 2017 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Associations of self-presentation on Facebook with mental health and personality variables: a systematic review - Twomey C, O'Reilly G.
Many investigations of the associations of self-presentation on Facebook with mental health and personality variables exist, but their findings have not yet been synthetized. We therefore carried out a narrative synthesis of 21 observational studies (combi... (Source: SafetyLit)
Source: SafetyLit - October 23, 2017 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Vote now for your health hero
The hard-working heroes who keep the NHS running – often in unsung ways – are being recognised in the second annual Health Heroes awards, organised by Skills for Health and sponsored by Health Education England. After a successful debut in 2016, this year the awards include three new categories: integrated team of the year, workforce planning team of the year and apprentice of the year, alongside the established clinical and operational services support worker of the year awards. UNISON is once more sponsoring one of the awards and head of health Sara Gorton commented: “Every day behind the scenes in the ...
Source: UNISON Health care news - October 23, 2017 Category: UK Health Authors: Tony Braisby Tags: Article News health care NHS one team one team for patient care Our Health Heroes Our Health Heroes Awards Source Type: news

RedHill lands new orphan drug designation, looks to grow commercial portfolio
At a time when RedHill Biopharma (NASDAQ: RDHL) is looking to grow its commercial portfolio, the company has landed U.S. Food and Drug Administration Orphan Drug Designation for MESUPRON for the treatment of pancreatic cancer – a market for which sales are expected to be $1.6 billion this year.  Benefits of the designation include development incentives and tax credits, as well as potentially a prescription drug user fee waiver and seven-year exclusive marketing period, if MESUPRON is ultimately… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 23, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

RedHill lands new orphan drug designation, looks to grow commercial portfolio
At a time when RedHill Biopharma (NASDAQ: RDHL) is looking to grow its commercial portfolio, the company has landed U.S. Food and Drug Administration Orphan Drug Designation for MESUPRON for the treatment of pancreatic cancer – a market for which sales are expected to be $1.6 billion this year.  Benefits of the designation include development incentives and tax credits, as well as potentially a prescription drug user fee waiver and seven-year exclusive marketing period, if MESUPRON is ultimately… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 23, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

The Digital Disruption
“We are now marketers in a data-driven world,” says Steve Mason, Multichannel and Marketing Cloud Expert at Sales Force. His epochal address, aimed squarely at the pharma industry during eyeforpharma’s Marketing and Customer Innovation event last year, could not have been clearer: get digitall y savvy or get left behind.It ’s an unassailable argument. Strides in digital innovation have redefined the ways we organise our time and space. The proliferation of digital channels - combined with the free flow of information readily available - has made the customer experience more integrated and personalis...
Source: EyeForPharma - October 23, 2017 Category: Pharmaceuticals Authors: Adam Chapman Source Type: news

Do & #039;s and Don & #039;ts of Medical Marketing
Promoting your practice using effective methods can be the difference between gaining and losing business. (Source: Physicians Practice)
Source: Physicians Practice - October 22, 2017 Category: Practice Management Authors: Manish Kumar Chauhan Tags: Blog Finance Marketing Operations Patients Source Type: news

Exploring cognitive decision-making processes, computer-focused cyber deviance involvement and victimization - Louderback ER, Antonaccio O.
OBJECTIVES:Investigate the relationship between thoughtfully reflective decision-making (TRDM) and computer-focused cyber deviance involvement and computer-focused cybercrime victimization.METHOD:Survey data collected from samples of 1,039 employee... (Source: SafetyLit)
Source: SafetyLit - October 21, 2017 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Misonix inks $11m Chinese licensing, manufacturing deal for SonaStar
Misonix (NSDQ:MSON) said today it inked an $11 million licensing and exclusive manufacturing deal with Chinese Hunan Xing Hang Rui Kang Bio-Technologies for Misonix’s SonaStar product line in China, Hong Kong and Macau. Through the agreement, Misonix will receive $5 million in upfront technology license fees and stocking orders as well as minimum royalty payments from the sale of SonaStar products of $2 million per yer between 2019 and 2021 and additional royalties through August 2027. “Working with Misonix represents a unique opportunity to add an important technology to our suite of products. SonaStar is...
Source: Mass Device - October 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Misonix Source Type: news

Hearing aid dev Eargo raises $45m in Series C
Hearing device developer Eargo said yesterday it closed the 1st tranche in a $45 million in a Series C investment round. Funding in the round was led by Nan Fung Life Sciences and joined by New Enterprise Associates, Charles and Helen Schwab and Maveron, with funds slated to support continued development, marketing and branding efforts the Mountain View, Calif.-based company said. “We believe Eargo will play a key role as an innovator in the global hearing technology space. Nan Fung Life Sciences is excited to be a part of Eargo’s mission of making hearing easy,” Nan Fung Life Sciences MD P...
Source: Mass Device - October 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Otolaryngology Ear, Nose & Throat Eargo Source Type: news

Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
SUMMIT, N.J.--(Healthcare Sales & Marketing Network)-- Celgene Corporation (NASDAQ: CELG) today announced that the GED-0301 (mongersen) phase III REVOLVE trial (CD-002) in Crohn's disease (CD) and the extension trial (SUSTAIN, CD-004) will discontinue. Cel... Biopharmaceuticals, Gastroenterology Celgene, mongersen, REVOLVE trial, Crohn's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 20, 2017 Category: Pharmaceuticals Source Type: news

Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States
TAIPEI, Taiwan, Oct. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClose™... Devices, Surgery Medeon Biodesign, AbClose, laparoscopy, port site wound closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 20, 2017 Category: Pharmaceuticals Source Type: news

WATCH: Class action lawsuits could take aim at diet soda makers
The proposed lawsuits allege, in part, the marketing of diet sodas by Coca-Cola, Pepsi and Dr. Pepper Snapple group, the three largest U.S. makers of carbonated beverages, are "false, misleading and unlawful" to consumers. (Source: ABC News: Health)
Source: ABC News: Health - October 20, 2017 Category: Consumer Health News Tags: GMA Source Type: news

Aadom announces specialty network program
Red Bank, N.J., October 15, 2017– The American Association of Dental Office Management (AADOM) is proud to launch a new initiative for office managers and practice administrators of specialty dental practices. This initiative was recently announced at the AADOM Annual Conference in Scottsdale, much to the enthusiasm of AADOM members. This program was created as a result of AADOM specialty members requesting to discuss challenges found in non-general dental practices. These unique situations include scheduling, marketing, billing& coding, specific to each specialty. AADOM responded to this challenge with the ...
Source: Dental Technology Blog - October 19, 2017 Category: Dentistry Source Type: news

Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications
WHIPPANY, N.J., Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Bayer is proud to announce today the appointment of Jennifer Brendel to Vice President of Communications for the company's Consumer Health Division in the United States. Brendel... Biopharmaceuticals, Personnel Bayer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 19, 2017 Category: Pharmaceuticals Source Type: news

Spinal Singularity Closes Seed Funding Round for $3.1M
SAN CLEMENTE, Calif., Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Derek Herrera, the founder of Spinal Singularity, announced the closing of an equity investment in the amount of $3.1M. The round was led by Baker & Eastlack Ventures and in... Devices, Urology, Venture Capital Spinal Singularity, Connected Catheter, Lower Urinary Tract Dysfunction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 19, 2017 Category: Pharmaceuticals Source Type: news

Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
Initial prescriptions will be 99 cents for a one month supply with refills starting at $79 per month, including shipping SAN DIEGO, Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmol... Biopharmaceuticals, Ophthalmology, Product Launch Imprimis Pharmaceuticals, Cyclosporine, Restasis, Dry Eye (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 19, 2017 Category: Pharmaceuticals Source Type: news

Exploring cognitive decision-making processes, computer-focused cyber deviance involvement and victimization - Louderback ER, Antonaccio O.
OBJECTIVES:Investigate the relationship between thoughtfully reflective decision-making (TRDM) and computer-focused cyber deviance involvement and computer-focused cybercrime victimization.METHOD:Survey data collected from samples of 1,039 employee... (Source: SafetyLit)
Source: SafetyLit - October 19, 2017 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Kent Imaging Revolutionizes Perfusion Imaging with their FDA-Cleared KD203
CALGARY, Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) - Kent Imaging, a leading provider of near infrared imaging solutions, announced today that the U.S. Food and Drug Administration (FDA) has cleared their multispectral Medical Imaging Device... Devices, Wound Care, FDA Kent Imaging, Kent camera, multispectral medical imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 19, 2017 Category: Pharmaceuticals Source Type: news

European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy(R) System
SUNNYVALE, Calif., Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accur... Devices, Oncology, Litigation Accuray, Varian Medical Systems, TomoTherapy, radiotherapy, IMRT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 19, 2017 Category: Pharmaceuticals Source Type: news

Johnson and Johnson Medical GmbH to Acquire Surgical Process Institute
Acquisition strengthens surgical solutions portfolio with innovative tools designed to minimize variability in care NORDERSTEDT, Germany, Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Medical GmbH today announced a defini... Devices, Surgery, Mergers & Acquisitions Johnson & Johnson, Surgical Process Institute (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 19, 2017 Category: Pharmaceuticals Source Type: news

Merck brings customers closer to gene therapy product commercialization
Merck today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has completed both a U.S. Food & Drug Administration (FDA) Pre-License inspection and a European Medicines Agency (EMA) Marketing Authorization Application inspection. (Source: World Pharma News)
Source: World Pharma News - October 19, 2017 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news

Health Highlights: Oct. 19, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Lawsuits Target Diet Soda Marketing The three largest carbonated beverage makers in the United States are being sued for allegedly misleading... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 19, 2017 Category: General Medicine Source Type: news

Q & amp;A: How Human-Centered Design Has Disrupted Cancer Treatment
Earlier this year, Varian Medical Systems made some big waves within the realm of cancer treatment when it introduced the Halcyon system, an entirely new device for cancer treatment that was designed to expand the availability of high-quality cancer care around the globe. The new system was designed to simplify and enhance virtually every aspect of image-guided volumetric intensity-modulated radiotherapy. The Halcyon technology platform was designed to empower clinicians to care for more patients by automating, streamlining, and simplifying virtually every aspect of treatment, from imaging patients in as little as 15 secon...
Source: MDDI - October 19, 2017 Category: Medical Devices Authors: Kristopher Sturgis Tags: MD & M Minneapolis Design Source Type: news

DarioHealth Gains CE Mark for iPhone 7 and iPhone 8 Smart Glucose Meter
DarioHealth Bringing its Lightning®-enabled Version to the UK Market CAESAREA, Israel, Oct. 18, 2017 -- (Healthcare Sales & Marketing Network) -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big ... Devices, Monitoring, Endocrinology, Regulatory DarioHealth, Blood Glucose Monitor, Blood Glucose (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2017 Category: Pharmaceuticals Source Type: news

Robert E. Abernathy Joins Haemonetics Board of Directors
BRAINTREE, Mass., Oct. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Haemonetics Corporation (NYSE: HAE) announced the election of Robert E. Abernathy, a seasoned healthcare executive, to its Board of Directors. Mr. Abernathy has led major medical... Devices, Personnel Haemonetics, plasma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2017 Category: Pharmaceuticals Source Type: news

MassDevice.com +5 | The top 5 medtech stories for October 17, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Less than half of healthcare professionals think medtech brands meet needs Roughly two-fifths of healthcare professionals say medical device brands aren’t meeting expectations, and failure to offer flexible contract optio...
Source: Mass Device - October 17, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System
PALO ALTO, Calif., Oct. 17, 2017 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced an 80-year-old male with head & neck cancer became the first patient in Europe to be treated on the Halcyon™ system at University Hospitals Le... Devices, Oncology Varian Medical Systems, Halcyon, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 17, 2017 Category: Pharmaceuticals Source Type: news

Menlo Therapeutics Expands its Management Team
REDWOOD CITY, Calif., Oct. 17, 2017 -- (Healthcare Sales & Marketing Network) -- Menlo Therapeutics Inc., a late stage biopharmaceutical company, is developing a neurokinin 1 (NK-1) receptor antagonist (serlopitant) for the treatment of pruritus (itch) as... Biopharmaceuticals, Dermatology, Personnel Menlo Therapeutics, serlopitant, pruritus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 17, 2017 Category: Pharmaceuticals Source Type: news

Seeking Communications and External Affairs Co-ordinator - Flexible location
Specifications:  1 FTESalary:  Competitive  Location: FlexibleApplication Closing Date: Monday 13 November 2017Cochrane ’s Communications and External Affairs Department (CEAD) seeks a Communications and External Affairs Co-ordinator to provide effective and efficient general administrative support services to CEAD, develop and implement Cochrane’s external affairs and fund-raising proposals, and to help co-ordi nateour already established communications activities along with supporting Cochrane’s annual events calendar.  Key Tasks:Communications planning support and responsi...
Source: Cochrane News and Events - October 17, 2017 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Bayer submits its extended half-life hemophilia A compound for marketing authorization in Japan (for specialized target groups only)
Pivotal studies with BAY94-9027 showed that bleed protection was achieved with extended dosing intervals (Source: Bayer Company News)
Source: Bayer Company News - October 17, 2017 Category: Pharmaceuticals Source Type: news

Estimates of Boomer Marketing Habits Show Gaps
2 hours ago ... Explore the full list of benefits available to you as an AARP Member; YOUR MONEY: Benefit of spending less calculator; QUIZ: Are you  ... (Source: AARP.org News)
Source: AARP.org News - October 16, 2017 Category: American Health Source Type: news

Understanding persuasive attributes of sports betting advertisements: a conjoint analysis of selected elements - Hing N, Vitartas P, Lamont M.
This study aimed to identify which attributes of sports bet... (Source: SafetyLit)
Source: SafetyLit - October 16, 2017 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

NuVasive Receives Expanded FDA 510(k) Clearance For TLX Interbody System Used In TLIF Procedures
New clearance for TLX™ system includes indications for use with allogeneic bone graft and in additional levels of the spine; Technology to be showcased at NASS 2017 SAN DIEGO, Oct. 16, 2017 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (N... Devices, Neurosurgery, Orthopaedic, FDA NuVasive, TLX interbody, TLIF, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2017 Category: Pharmaceuticals Source Type: news

Sigilon Therapeutics Introduces Scientific Advisory Board for Guiding Development of Afibromer(TM) Living Therapeutics
CAMBRIDGE, Mass., Oct. 16, 2017 -- (Healthcare Sales & Marketing Network) -- Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants, today announced the formation of a scientific advisor... Biopharmaceuticals, Personnel Sigilon Therapeutics, Afibromer, living therapeutic implants (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2017 Category: Pharmaceuticals Source Type: news

Illumina Ventures Closes $230 Million Fund
Genomics-focused fund will support breakthroughs in life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health SAN FRANCISCO, Oct. 16, 2017 -- (Healthcare Sales & Marketing Network) -- Illumi... Biopharmaceuticals, Personalized Medicine, Venture Capital Illumina Ventures, genomics, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2017 Category: Pharmaceuticals Source Type: news

BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn(R) in ALS
Trial supported by a $16M non-dilutive grant from CIRM Top-line data are expected in 2019 HACKENSACK, N.J. and PETACH TIKVA, Israel, Oct. 16, 2017 -- (Healthcare Sales & Marketing Network) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) today an... Regenerative Medicine, Neurology BrainStorm Cell Therapeutics, NurOwn , stem cell, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2017 Category: Pharmaceuticals Source Type: news

Skepticism at Launch of the Foundation for a Smoke-Free World Skepticism at Launch of the Foundation for a Smoke-Free World
Some tobacco control experts are skeptical because the foundation is funded by a large tobacco manufacturer, which is now marketing smokeless nicotine-delivery products.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Ashfield to host workshop at the 14th annual eyeforpharma Patient Summit Europe 2017, London, UK
Ashfield is proud to be a supporting sponsor of the conference, taking place 19 – 20 October, and will be hosting a workshop session at 14:50 on day 1, where Jessica Brueggeman, EVP Health Behaviour Group, MicroMass Communications, and Jo Fearnhead-Wymbs, Patient Engagement Director, Ashfield Healthcare Communications, will be sharing insight into: The key to improving patient outcomes and brand performance Traditional pharma marketing approaches that only provide education and information are not enough to change patient behaviour Evidence-based strategies from behavioural science and health psychology provide a ro...
Source: Ashfield Healthcare News - October 16, 2017 Category: Pharmaceuticals Authors: Sarah Edwards Tags: Ashfield Source Type: news

The Fall and television noir - Steenberg L.
This article analyzes the Belfast-set BBC series The Fall (2013-) as an illustrative example of television noir. It aims to use noir scholarship to investigate The Fall's complex gender politics and genre position, and, more significantly, to use The Fall ... (Source: SafetyLit)
Source: SafetyLit - October 16, 2017 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Mobile apps for suicide prevention: review of virtual stores and literature - de la Torre I, Castillo G, Arambarri J, L ópez-Coronado M, Franco MA.
BACKGROUND: The best manner to prevent suicide is to recognize suicidal signs and signals, and know how to respond to them. OBJECTIVE: We aim to study the existing mobile apps for suicide prevention in the literature and the most commonly used virt... (Source: SafetyLit)
Source: SafetyLit - October 16, 2017 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Marketing study examines what types of searches click for car buyers
(University of Texas at Dallas) A new study from The University of Texas at Dallas examines how consumers allocated their time when searching offline and on the internet as they shopped for a new automobile, and what the outcomes were for price satisfaction. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 16, 2017 Category: International Medicine & Public Health Source Type: news

Suicidality in German-speaking school psychiatry : thematization in textbooks from 1803 until the present - Gnoth M, Glaesmer H, Steinberg H.
This study was guided by the following questions: has suicidality been p... (Source: SafetyLit)
Source: SafetyLit - October 14, 2017 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

FDA clears ultrasound transducer from Philips
The U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance...Read more on AuntMinnie.comRelated Reading: Philips launches new cardiac SPECT camera at ASNC show Philips launches new ob/gyn ultrasound at ISUOG 2017 Philips joins healthcare safety coalition Philips signs on as RBMA sponsor Philips tackles DoseWise Portal security vulnerability (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 13, 2017 Category: Radiology Source Type: news

Olympus Announces Continued Expansion of Its GI Endoscopic Device Line with ESD Innovations
SB Knives, Eleview and Guardian Driving Complete Solutions for Gastroenterologists CENTER VALLEY, Pa., Oct. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and delivering innovative solutions for m... Devices, Gastroenterology, Product Launch Olympus Medical Systems, EndoTherapy, endoscopy, Submucosal Dissection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2017 Category: Pharmaceuticals Source Type: news

Magnet Status: Superior Care or Marketing Gimmick?
(MedPage Today) -- Some nurses charge the program has strayed from its original mission (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 13, 2017 Category: American Health Source Type: news

Inception Companies Hires Agency Titan Matt Giegerich to Serve as New CEO for its Two Lead Businesses
Fairfield, NJ -- (Healthcare Sales & Marketing Network) -- The Inception Companies announce the appointment of Matt Giegerich, longtime CEO of WPP’s Ogilvy CommonHealth, to serve as CEO for Inception’s two largest business units. During his 25-year tenure ... Personnel Inception Companies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2017 Category: Pharmaceuticals Source Type: news